C, shares how she saved Dr Jacquelyn Lacera’s life from a near-fatal cardiovascular event while aboard a flight from Hawaii.

Edgewise Therapeutics shares tumbled more than 20% Wednesday after the developmental drug company issued the results of its ...

Cadrenal Therapeutics, Inc. (Nasdaq: CVKD), a late-stage biopharmaceutical company focused on the development of tecarfarin, a new Phase 3-ready oral vitamin K antagonist anticoagulant, today ...

Shares of Edgewise Therapeutics and Cytokinetics diverged Wednesday after safety questions highlighted a heart disease study from Edgewise.

including Left Ventricular Assisted Devices (LVADs). The Company also received ODD and fast-track status for tecarfarin in end-stage kidney disease and atrial fibrillation (ESKD+AFib). Cadrenal is ...

Atrial fibrillation independently increases dementia risk by 21% in adults under the age of 70, new research indicates.

Atrial fibrillation diagnosed before age 70 years was associated with a 21% increased risk for dementia and a 36% increased ...